Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Thomas J. Comstock"'
Publikováno v:
Annals of Pharmacotherapy. 34:593-599
OBJECTIVE: The University of Pittsburgh Nephrology Pharmaceutical Care Preceptorship (NPCP) program was conceived to acquaint health system pharmacists with the pharmacotherapeutic management of dialysis patients, enhance the delivery of pharmaceutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9815230718b86203946f14e89bc4581d
https://doi.org/10.1345/aph.19245
https://doi.org/10.1345/aph.19245
Autor:
Thomas J. Comstock
Publikováno v:
Journal of Pharmacy Practice. 6:106-112
End-stage renal disease (ESRD) afflicts more than 200,000 patients in the United States today, and they undergo chronic dialysis or transplantation in order to sustain life. The primary causes of treated ESRD today are diabetes mellitus, hypertension
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a772fc3a8b1fb49041adf54023d2292
https://doi.org/10.1177/089719009300600303
https://doi.org/10.1177/089719009300600303
Autor:
James Lile, Donald F. Brophy, Lori D. Wazny, Todd W. B. Gehr, Thomas J. Comstock, Jürgen Venitz
Publikováno v:
Pharmacotherapy. 21:1017-1019
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f847e644d242629e04896ff9787484a
https://doi.org/10.1592/phco.21.11.1017.34514
https://doi.org/10.1592/phco.21.11.1017.34514
Publikováno v:
The Annals of pharmacotherapy. 41(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e8e5459983656c2fcad34d0380fc971
https://pubmed.ncbi.nlm.nih.gov/17940121
https://pubmed.ncbi.nlm.nih.gov/17940121
Autor:
Joanna Q. Hudson, Thomas J. Comstock
Publikováno v:
Clinical therapeutics. 23(10)
Background: Availability of recombinant human erythropoietin (rHuEPO) has improved the treatment of anemia due to chronic kidney disease (CKD). Iron deficiency is the most common cause of resistance to rHuEPO therapy, contributing to ineffective eryt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::955a666ed0b56fca2ddc2b9100f007f2
https://pubmed.ncbi.nlm.nih.gov/11726002
https://pubmed.ncbi.nlm.nih.gov/11726002
Publikováno v:
Pharmacotherapy. 21(2)
Study Objective. To evaluate the pharmacokinetics of enoxaparin in end-stage renal disease (ESRD), and determine if dosage reduction is necessary to maintain antifactor Xa activity concentrations within the therapeutic range. Design. Prospective, sin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8c8eff168c0330f31ae0bc4174c5dd1
https://pubmed.ncbi.nlm.nih.gov/11718492
https://pubmed.ncbi.nlm.nih.gov/11718492
Autor:
Howard N. Bockbrader, Robert W. Schultz, Allen J. Sedman, Thomas J. Comstock, Robert A. Blum, Deitrich Tuerck, Janice A. Busch, E. Keller, Phillip A. Reece, Petra Reetze, Domenic A. Sica
Publikováno v:
Clinical pharmacology and therapeutics. 56(2)
The pharmacokinetics of oral gabapentin (400 mg) was studied in normal subjects and in subjects with various degrees of renal function. Sixty subjects participated in this three-center study. None of the subjects were receiving hemodialysis. Plasma a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1daed6498993d11c739465fa420aca4a
https://pubmed.ncbi.nlm.nih.gov/8062491
https://pubmed.ncbi.nlm.nih.gov/8062491
Autor:
Thomas J. Comstock, James V. Felicetta, Kerry B. Hafner, Neal R. Cutler, Matthew R. Weir, Harry M. Serfer, Gary L. Huber, Glen D. Park
Publikováno v:
American heart journal. 123(4 Pt 1)
This trial was performed to determine the safe and effective dosage range of once daily diltiazem (diltiazem CD) capsules for treatment of essential hypertension. Patients with essential hypertension having supine diastolic blood pressure values grea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f722eef53bd6a7f9b1d829cd53ba681
https://pubmed.ncbi.nlm.nih.gov/1549966
https://pubmed.ncbi.nlm.nih.gov/1549966
Publikováno v:
European journal of clinical pharmacology. 39(2)
We determined plasma methocarbamol concentrations over 24 h following a 1.5 g methocarbamol dose (off-dialysis day) to 8 chronic haemodialysis patients and compared these results to those from 17 healthy male volunteers. The harmonic mean elimination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4caa497c6223513f4f81bdf64bf8fe85
https://pubmed.ncbi.nlm.nih.gov/2253675
https://pubmed.ncbi.nlm.nih.gov/2253675
Publikováno v:
Nephrology Dialysis Transplantation; Feb2004, Vol. 19 Issue 2, p400-405, 6p